CARL GOLDFISCHER
CIK 1110780 · last filed 2025-06-20
CARL GOLDFISCHER is a corporate insider who has filed 80 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for GLTO, was dated Jun 20, 2025. Across all open-market trades the lifetime net is −$25.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $63.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$63.55M
7
80
-$25.74M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | 29,019 | $28.69 | $832.6K | $0 | 7 | 2025-06-20 |
| IMRA | Director | 703,380 | $17.02 | $11.97M | $0 | 2 | 2022-06-03 |
| Epizyme, Inc. (EPZM) Delisted | Director | 3,403,005 | $1.47 | $5.00M | -$25.72M | 18 | 2022-05-19 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | 4,294 | $32.48 | $139.5K | -$584.7K | 11 | 2019-02-08 |
| ReShape Weightloss Inc. (ETRM) Delisted | Director | 0 | — | — | $9.81M | 21 | 2017-05-31 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Director | 314,227 | — | — | $378.0K | 10 | 2011-06-10 |
| MAPP | Director | 1,859,987 | $27.73 | $51.58M | -$9.63M | 6 | 2010-05-21 |
Recent Filings
80 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-20 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-16 | — | Disp (D) | −3,403,005 | $0 | |
| 2022-06-15 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | IMRA | Grant (A) | — | $0 | EDGAR |
| 2022-05-19 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | +8,994 | $0 | EDGAR |
| 2021-11-19 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-30 | IMRA | Grant (A) | — | $0 | EDGAR |
| 2021-06-15 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | +8,060 | $0 | EDGAR |